When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Patients with eosinophilic esophagitis are at higher risk of developing a psychiatric disorder during the first 5 years after diagnosis, according to new research.
Patients with eosinophilic esophagitis are at higher risk of developing a psychiatric disorder during the first 5 years after diagnosis, according to new research.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
What type of food elimination treatment has demonstrated effectiveness among pediatric patients with eosinophilic esophagitis? Take our quiz and find out!
What type of food elimination treatment has demonstrated effectiveness among pediatric patients with eosinophilic esophagitis? Take our quiz and find out!
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma? Take our quick quiz to find out!
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma? Take our quick quiz to find out!
In treating gastrointestinal disorders, do gastroenterologists work better alone or as part of a multidisciplinary team? Answer our poll to understand the approaches better!
In treating gastrointestinal disorders, do gastroenterologists work better alone or as part of a multidisciplinary team? Answer our poll to understand the approaches better!
Investigators recently looked at whether obesity, smoking, drinking coffee, and other factors may be associated with diverticular disease. Take our quiz to find out what they revealed!
Investigators recently looked at whether obesity, smoking, drinking coffee, and other factors may be associated with diverticular disease. Take our quiz to find out what they revealed!
Researchers have found a combination of two agents to demonstrate superior efficacy and a favorable benefit-risk profile among patients with unresectable hepatocellular carcinoma. Take our quiz to find out which combo could improve overall...
Researchers have found a combination of two agents to demonstrate superior efficacy and a favorable benefit-risk profile among patients with unresectable hepatocellular carcinoma. Take our quiz to find out which combo could improve overall...
There’s no upper age limit for colorectal cancer (CRC) screening! But age alone is not the only deciding factor when offering CRC to older patients. What else should be considered?
There’s no upper age limit for colorectal cancer (CRC) screening! But age alone is not the only deciding factor when offering CRC to older patients. What else should be considered?
The adenoma detection rate is an essential quality indicator for endoscopists performing colonoscopies for colorectal cancer screening as it is associated with postcolonoscopy colorectal cancers. Take our quiz to find out more about this...
The adenoma detection rate is an essential quality indicator for endoscopists performing colonoscopies for colorectal cancer screening as it is associated with postcolonoscopy colorectal cancers. Take our quiz to find out more about this...
Are the odds of histologic, symptomatic, and endoscopic response to topical corticosteroids among patients with eosinophilic esophagitis associated with weight? Take our quiz to find out!
Are the odds of histologic, symptomatic, and endoscopic response to topical corticosteroids among patients with eosinophilic esophagitis associated with weight? Take our quiz to find out!
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Patients with eosinophilic esophagitis are at higher risk of developing a psychiatric disorder during the first 5 years after diagnosis, according to new research.
Patients with eosinophilic esophagitis are at higher risk of developing a psychiatric disorder during the first 5 years after diagnosis, according to new research.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.